Nuwellis (NUWE) Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

Go back to Nuwellis (NUWE) Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

Baxter International (BAX) PT Lowered to $40 at UBS

May 3, 2024 7:03 AM EDT

UBS analyst Danielle Antalffy lowered the price target on Baxter International (NYSE: BAX) to $40.00 (from $42.00) while maintaining a Neutral rating.

The analyst comments "Our modestly lower $40 PT is derived by applying a ~12x P/E multiple to our Q5-Q8 sales estimate. Our... More

Baxter International (BAX) PT Lowered to $43 at Jefferies

May 2, 2024 3:59 PM EDT

Jefferies analyst Matthew Taylor lowered the price target on Baxter International (NYSE: BAX) to $43.00 (from $45.00) while maintaining a Hold rating.

The analyst comments "BAX reported 1Q24 sales of $3.59B +3% xfx vs cons $3.55B and EPS of $0.65 vs cons $0.61. BAX continues to... More